StockData
Pfizer Inc logo

Pfizer Inc (PFE) income statement

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.06−0.41 (-1.44%)

Close on Nov 18, 2026Market cap $159.93BP/E 36.9Yield 6.13%

Pfizer Inc income statement

Ratios

Latest available, balances at Jun 28, 2026

Profitability, TTM

Gross margin
73.2%
Operating margin
–
Net margin
6.8%
Return on equity, FY2025
8.9%

Financial strength

Current ratio
1.27
Debt to equity
0.74
Debt to assets
31.4%
Cash to current liabilities
3.0%

Valuation

P/E ratio
36.9
Price to sales
2.51
Price to book
1.88
Dividend yield
6.13%

See a number that looks wrong?